|
ANKRD32 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.180290E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.939060E-03 |
| Normal-vs-Stage2 |
4.33850000000069E-05 |
| Normal-vs-Stage3 |
7.65000000000349E-05 |
| Normal-vs-Stage4 |
8.784700E-03 |
| Stage1-vs-Stage2 |
1.762050E-02 |
| Stage1-vs-Stage3 |
6.380400E-02 |
| Stage1-vs-Stage4 |
5.937600E-01 |
| Stage2-vs-Stage3 |
3.610200E-01 |
| Stage2-vs-Stage4 |
1.696970E-01 |
| Stage3-vs-Stage4 |
4.542600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.440500E-04 |
| Normal-vs-AfricanAmerican |
1.088100E-02 |
| Normal-vs-Asian |
2.278800E-01 |
| Caucasian-vs-AfricanAmerican |
7.191600E-01 |
| Caucasian-vs-Asian |
7.635800E-02 |
| AfricanAmerican-vs-Asian |
1.255190E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.757000E-04 |
| Normal-vs-Female |
2.217100E-04 |
| Male-vs-Female |
6.926200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.923600E-03 |
| Normal-vs-Age(41-60Yrs) |
6.14589999999859E-05 |
| Normal-vs-Age(61-80Yrs) |
1.435990E-04 |
| Normal-vs-Age(81-100Yrs) |
1.696350E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.659900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.857800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.017800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.254600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.769200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.781800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.533200E-01 |
| Classical-VS-Follicular |
1.24020000047409E-07 |
| Classical-VS-Other |
2.101200E-01 |
| Classical-VS-Normal |
9.944000E-03 |
| Tall-VS-Follicular |
1.029790E-02 |
| Tall-VS-Other |
3.501000E-01 |
| Tall-VS-Normal |
3.052200E-02 |
| Follicular-VS-Other |
6.303000E-01 |
| Follicular-VS-Normal |
1.77560000036436E-08 |
| Other-VS-Normal |
3.835500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.58963999999928E-05 |
| Normal-vs-N1 |
8.795600E-02 |
| N0-vs-N1 |
4.214000E-02 |
|
|
